{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:48:04Z","timestamp":1781650084658,"version":"3.54.5"},"reference-count":25,"publisher":"Scientific Scholar","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Nephrol"],"published-print":{"date-parts":[[2010]]},"DOI":"10.4103\/0971-4065.70839","type":"journal-article","created":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T13:05:39Z","timestamp":1285938339000},"page":"121","source":"Crossref","is-referenced-by-count":20,"title":["Aminoglycoside use in renal failure"],"prefix":"10.25259","volume":"20","author":[{"given":"S","family":"Nayak-Rao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0971-4065.70839-1","first-page":"85","volume-title":"Aminoglycosides: The complex problem of antibiotic mechanisms and clinical applications","author":"Montie","year":"1995","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key-10.4103\/0971-4065.70839-2","first-page":"61","volume-title":"Aminoglycosides","author":"Lortholary","year":"1995","journal-title":"Med Clin North Am"},{"key":"key-10.4103\/0971-4065.70839-3","first-page":"33","volume-title":"Prevention of drun induced nephrotoxicity in the intensive care unit","author":"Hock","year":"1995","journal-title":"J Crit Care"},{"key":"key-10.4103\/0971-4065.70839-4","first-page":"705","volume-title":"Drug induced nephrotoxicity","author":"Choudhary","year":"1997","journal-title":"Med Clin North Am"},{"key":"key-10.4103\/0971-4065.70839-5","first-page":"399","volume-title":"Once daily aminoglycoside therapy","author":"Gilbert","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0971-4065.70839-6","first-page":"39","volume-title":"Aminoglycosides: Single or multiple daily dosing.Meta-analysis on efficacy and safety?","author":"Galloe","year":"1995","journal-title":"Eur J Clin Pharmacol"},{"key":"key-10.4103\/0971-4065.70839-7","first-page":"796","volume-title":"A meta-analysis of the relative efficacy and toxicity of aminoglycosides","author":"Ali","year":"1997","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0971-4065.70839-8","first-page":"885","volume-title":"Antimicrobial practice.Development of guidelines for gentamicin dosing","author":"Thomson","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/0971-4065.70839-9","first-page":"1158","volume-title":"The aminoglycosides","author":"Edson","year":"1991","journal-title":"Mayo Clin Proc"},{"key":"key-10.4103\/0971-4065.70839-10","first-page":"148","volume-title":"Therapeutic aminoglucoside monitoring in renal failure patients","author":"Keller","year":"1987","journal-title":"Ther Drug Monit"},{"key":"key-10.4103\/0971-4065.70839-11","first-page":"637","volume-title":"Pharmacokinetics of gentamicin in 957 patients with varying renal function dosed once daily","author":"Kirkpatrick","year":"1999","journal-title":"Br J Clin Pharamcol"},{"key":"key-10.4103\/0971-4065.70839-12","first-page":"84","volume-title":"Pharmacokinetics of netilmicin in renal insufficiency and hemodialysis","author":"Herrero","year":"1988","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"key-10.4103\/0971-4065.70839-13","first-page":"997","volume-title":"Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy","author":"Pea","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"key-10.4103\/0971-4065.70839-14","first-page":"9","volume-title":"Aminoglycoside in intermittent hemodialysis: Pharmacokinetics with individual dosing","author":"Dager","year":"2006","journal-title":"Ann Pharmacother"},{"key":"key-10.4103\/0971-4065.70839-15","first-page":"1259","volume-title":"Dosing of gentamicin in patients with end stage renal disease receiving hemodialysis","author":"Teiger","year":"2006","journal-title":"J Clin Pharmacol"},{"key":"key-10.4103\/0971-4065.70839-16","unstructured":"Aronoff GR, Bennett WM, Burns JS, Brier ME, Kasbekar N, Mueller BA, et al. Drug prescribing in renal failure: Dosing guidelines for adults and children, 5 th Ed. Philadelphia: American College of Physicians; 2007."},{"key":"key-10.4103\/0971-4065.70839-17","first-page":"355","volume-title":"Influence of hemodialysis on gentamicin pharmacokinetics, removal during hemodialysis and recommended dosing","author":"Sowinski","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"key-10.4103\/0971-4065.70839-18","first-page":"222","volume-title":"Characterization of gentamicin pharmacokinetics in patients hemodialyzed with high-flux polysulphone membranes","author":"Amin","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/0971-4065.70839-19","first-page":"47","volume-title":"Heterogenecity in gentamicin clearance between high-efficiency hemodialysers","author":"Agarwal","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/0971-4065.70839-20","first-page":"236","volume-title":"Amikacin pharmacokinetics during continuous ambulatory peritoneal dialysis","author":"Smeltzer","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0971-4065.70839-21","first-page":"107","volume-title":"Peritoneal dialysis related infections recommendations: 2005 Update","author":"Piriano","year":"2005","journal-title":"Perit Dial Int"},{"key":"key-10.4103\/0971-4065.70839-22","first-page":"179","volume-title":"A prospective randomized comparison of single versus multidose gentamicin in the treatment of CAPD peritonitis","author":"Lye","year":"1995","journal-title":"Adv Perit Dial"},{"key":"key-10.4103\/0971-4065.70839-23","first-page":"670","volume-title":"Emperical aminoglucodies for peritonitis do not affect residual renal function","author":"Baker","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/0971-4065.70839-24","first-page":"675","volume-title":"Pharmacokinetics of amikacin during continuous veno-venous hemofiltration","author":"Armandariz","year":"1990","journal-title":"Crit Care Med"},{"key":"key-10.4103\/0971-4065.70839-25","first-page":"101","volume-title":"A pharmacokinetic basis for improving therapeutic outcomes of aminoglycoside therapy during continuous venovenous hemodiafiltration","author":"Spooner","year":"2007","journal-title":"Crit Care"}],"container-title":["Indian Journal of Nephrology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T19:41:51Z","timestamp":1712173311000},"score":1,"resource":{"primary":{"URL":"https:\/\/indianjnephrol.org\/aminoglycoside-use-in-renal-failure\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"alternative-id":["70839"],"URL":"https:\/\/doi.org\/10.4103\/0971-4065.70839","relation":{},"ISSN":["0971-4065"],"issn-type":[{"value":"0971-4065","type":"print"}],"subject":[],"published":{"date-parts":[[2010]]}}}